Novel TIA biomarkers identified by mass spectrometry-based proteomics

International Journal of Stroke

Volumn 10, Issue 8, 2015, Pages 1204-1211

  George, Paul M ^a   Mlynash, Michael ^a   Adams, Christopher M ^a   Kuo, Calvin J ^b   Albers, Gregory W ^a   Olivot, Jean Marc ^c  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Pierre Paul Riquet Hospital   (France)

Author keywords

biomarkers; ceruloplasmin; clinical trial; platelet basic protein; proteomics; transient ischemic attack

Indexed keywords

CERULOPLASMIN; COMPLEMENT COMPONENT C8; COMPLEMENT COMPONENT C8 GAMMA; PENICILLIN BINDING PROTEIN; UNCLASSIFIED DRUG; BETA THROMBOGLOBULIN; BIOLOGICAL MARKER; PPBP PROTEIN, HUMAN;

AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRANSIENT ISCHEMIC ATTACK; BLOOD; BLOOD ANALYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; PROCEDURES; SINGLE BLIND PROCEDURE; VALIDATION STUDY;

AGED; BETA-THROMBOGLOBULIN; BIOMARKERS; BLOOD CHEMICAL ANALYSIS; CERULOPLASMIN; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MASS SPECTROMETRY; PROSPECTIVE STUDIES; PROTEOMICS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; STROKE;

EID: 84954401472     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12603     Document Type: Article

References (28)

1. Giles MF, Rothwell PM,. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2007; 6:1063-72.
2. Johnston SC, Gress DR, Browner WS, Sidney S,. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000; 284:2901-6.
3. Castle J, Mlynash M, Lee K,. Agreement regarding diagnosis of transient ischemic attack fairly low among stroke-trained neurologist. Stroke 2010; 41:1367-70.
4. Koudstaal PJ, van Gijn J, Staal A, Duivenvoorden HJ, Gerritsma JG, Kraaijeveld CL,. Diagnosis of transient ischemic attacks: improvement of interobserver agreement by a check-list in ordinary language. Stroke 1986; 17:723-8.
5. Prabhakarn S, Silver AJ, Warrior L, McClenathan B, Lee VH,. Misdiagnosis of transient ischemic attacks in the emergency room. Cerebrovasc Dis 2008; 26:630-5.
6. Krol AL, Coutts SB, Simon JE, Hill MD, Sohn CH, Demchuk AM,. Perfusion MRI abnormalities in speech or motor transient ischemic attack patients. Stroke 2005; 36:2487-9.
7. Mlynash M, Olivot JM, Tong DC,. Yield of combined perfusion and diffusion MR imaging in hemispheric TIA. Neurology 2009; 72:1127-33.
8. Burns JD, Rabinstein AA, Roger VL,. Incidence and predictors of myocardial infarction after transient ischemic attack: a population-based study. Stroke 2011; 42:935-40.
9. Clark TG, Murphy MF, Rothwell PM,. Long term risks of stroke, myocardial infarction, and vascular death in 'low risk' patients with a non-recent transient ischemic attack. J Neurol Neurosurg Psychiatry 2003; 74:577-80.
10. Rothwell PM, Giles RF, Chandratheva A,. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007; 370:1432-42.
11. Jove M, Mauri-Capdevila G, Suarez I,. Metabolomics predicts stroke recurrence after transient ischemic attack. Neurology 2015; 84:36-45.
12. Sharp FR, Jickling GC,. Whole genome expression of cellular response to stroke. Stroke 2013; 44:S23-5.
13. Whiteley W, Chong WL, Sengupta A, Sandercock P,. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke 2009; 40:e380-9.
14. Whiteley W, Tian Y, Jickling GC,. Blood biomarkers in stroke: research and clinical practice. Int J Stroke 2012; 7:435-9.
15. Schramm A, Apostolov O, Sitek B,. Proteomics: techniques and applications in cancer research. Klin Padiatr 2003; 215:293-7.
16. Ansong C, Purvine SO, Adkins JN, Lipton MS, Smith RD,. Proteogenomics: needs and roles to be filled by proteomics in genome annotation. Brief Funct Genomic Proteomic 2008; 7:50-62.
17. Humphrery-Smith I, Cordwell SJ, Blackstock WP,. Proteome research: Complementarity and limitations with respect to the RNA and DNA worlds. Electrophoresis 1997; 18:1217-42.
18. Guerrero C, Tagwerker C, Kaiser P, Huang L,. An integrated mass spectrometry-based proteomic approach: quantitative analysis of tandem affinity-purified in vivo cross-linked protein complexes (QTAX) to decipher the 26 S proteasome-interacting network. Mol Cell Proteomics 2006; 5:366-78.
19. Zhang C, Thornton MA, Kowalska MA,. Localization of distal regulatory domains in the megakaryocyte-specific platelet basic protein/platelet factor 4 gene locus. Blood 2001; 98:610-7.
20. Ehlert JE, Ludwig A, Grimm TA, Lindner B, Flad H-D, Brandt E,. Down-regulation of neutrophil functions by the ELR+ CXC chemokine platelet basic protein. Blood 2000; 96:2965-72.
21. Brandt E, Petersen F, Ludwig A, Ehlert JE, Bock L, Flad H-D,. The β-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation. J Leukoc Biol 2000; 67:471-8.
22. Kowalska MA, Rauova L, Poncz M,. Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis. Thromb Res 2010; 125:292-6.
23. Brochériou I, Maouche S, Durand H,. Antagonistic regulation of macrophage phenotype by M-CSF and GM-CSF: implication in atherosclerosis. Atherosclerosis 2011; 214:316-24.
24. Yoo K-Y, Hwang IK, Eum WS,. Differential effects and changes of ceruloplasmin in the hippocampal CA1 region between adult and aged gerbils after transient cerebral ischemia. Neurosci Res 2006; 55:610-7.
25. Texel SJ, Zhang J, Camandola S,. Ceruloplasmin deficiency reduces levels of iron and BDNF in the cortex and striatum of young mice and increases their vulnerability to stroke. PLoS ONE 2011; 6:e25077.
26. D'Souza B, D'Souza V, Sowmya S,. A comparative study on oxidative stress and antioxidant status in ischemic stroke patients with and without diabetes. Indian J Clin Biochem 2008; 23:218-22.
27. Nadarajan VPR, Johnson J, Werring DJ,. Transient ischaemic attacks: mimics and chameleons. Pract Neurol 2014; 14:23-31.
28. Johnston SC, Rothwell PM, Nguyen-Huynh MN,. Validation and refinement of scores to predict very early stroke risk after transient ischemic attack. Lancet 2007; 369:283-92.